| Pharmaceutical Information |
| Drug Name |
Levocabastine hydrochloride |
| Drug ID |
BADD_D01270 |
| Description |
Levocabastine is a selective second-generation H1-receptor antagonist used for allergic conjunctivitis. Levocabastine was discovered at Janssen Pharmaceutica in 1979. |
| Indications and Usage |
As an ophthalmic for the temporary relief of the signs and symptoms of seasonal allergic conjunctivitis. Also used as a nasal spray for allergic rhinitis. |
| Marketing Status |
Discontinued |
| ATC Code |
R01AC02; S01GX02 |
| DrugBank ID |
DB01106
|
| KEGG ID |
D01717
|
| MeSH ID |
C047340
|
| PubChem ID |
54384
|
| TTD Drug ID |
D08SEI
|
| NDC Product Code |
65089-0042 |
| Synonyms |
levocabastine | 1-(4-cyano-4-(4-fluorophenyl)cyclohexyl)-3-methyl-4-phenyl-4-piperidinecarboxylic acid | livostin | livocab | levophta | levocabastine hydrochloride | lévophta | Bilina |
|
| Chemical Information |
| Molecular Formula |
C26H30ClFN2O2 |
| CAS Registry Number |
79547-78-7 |
| SMILES |
CC1CN(CCC1(C2=CC=CC=C2)C(=O)O)C3CCC(CC3)(C#N)C4=CC=C(C=C4)F.Cl |
| Chemical Structure |
|
|
| ADR Related Proteins Induced by Drug |
| ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
| Not Available | Not Available | Not Available | Not Available | Not Available |
|
| ADRs Induced by Drug |
|
|
